Predicting chemoinsensitivity in breast cancer with ’omics/digital pathology data fusion

Royal Society Open Science

Volumn 3, Issue 2, 2016, Pages

  Savage, Richard S ^a,b   Yuan, Yinyin ^c  

^a Systems Biology Centre   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Bayesian; Breast cancer; Data integration

Indexed keywords

EID: 84958093312     PISSN: None     EISSN: 20545703     Source Type: Journal    
DOI: 10.1098/rsos.140501     Document Type: Article

References (31)

1. Gray J, Druker B. 2012 Genomics: the breast cancer landscape. Nature 486, 328-329. (doi: 10. 1038/ 486328a).
2. Lander E. 2011 Initial impact of the sequencing of the human genome. Nature 470, 187-197. (doi: 10. 1038/nature09792).
3. Paik S et al. 2004 A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N. Engl. J. Med. 351, 2817-2826. (doi: 10. 1056/NEJMoa041588).
4. Van't Veer L et al. 2002 Gene expression profiling predicts clinical outcome of breast cancer. Nature 415, 530-536. (doi: 10. 1038/415530a).
5. Yuan Y et al. 2012 Quantitative image analysis of cellular heterogeneity in breast tumors complements genomic profiling. Sci. Transl. Med. 4, 161er6. (doi: 10. 1126/scitranslmed. 3005298).
6. Futschik M, Sullivan M, Reeve A, Kasabov N. 2003 Prediction of clinical behaviour and treatment for cancers. Appl. Bioinform. 2, 53-58.
7. Nevins JR, Huang ES, Dressman H, Pittman J, Huang AT, West M. 2003 Towards integrated clinicogenomic models for personalized medicine: combining gene expression signatures and clinical factors in breast cancer outcomes prediction. Hum. Mol. Genet. 12, R153-R157. (doi: 10. 1093/hmg/ ddg287).
8. Pittman J et al. 2004 Integrated modeling of clinical and gene expression information for personalized prediction of disease outcomes. Proc. Natl Acad. Sci. USA 101, 8431-8436. (doi: 10. 1073/pnas. 0401736101).
9. Stephenson AJ, Smith A, Kattan MW, Satagopan J, Reuter VE, Scardino PT, Gerald WL. 2005 Integration of gene expression profiling and clinical variables to predict prostate carcinoma recurrence after radical prostatectomy. Cancer 104, 290-298. (doi: 10. 1002/ cncr. 21157).
10. Gevaert O, Smet FD, Timmerman D, Moreau Y, Moor BD. 2006 Predicting the prognosis of breast cancer by integrating clinical and microarray data with Bayesian networks. Bioinformatics 22, e184-e190. (doi: 10. 1093/bioinformatics/btl230).
11. Boulesteix A, Porzelius C, Daumer M. 2008 Microarray-based classification and clinical predictors: on combined classifiers and additional predictive value. Bioinformatics 24, 1698-1706. (doi: 10. 1093/bioinformatics/btn262).
12. Daemen A, Gevaert O, Ojeda F, Debucquoy A, Suykens JAK, Sempoux C, Machiels J-P, Haustermans K, De Moor B. 2009 A kernel-based integration of genome-wide data for clinical decision support. Genome Med. 1, 39. (doi: 10. 1186/gm39).
13. Obulkasim A, Meijer G, van deWiel M. 2011 Stepwise classification of cancer samples using clinical and molecular data. BMC Bioinform. 12, 422. (doi: 10. 1186/1471-2105-12-422).
14. Savage RS, Ghahramani Z, Griffin JE, de la Cruz BJ, Wild DL. 2010 Discovering transcriptional modules by Bayesian data integration. Bioinformatics 26, i158-i167. (doi: 10. 1093/bioinformatics/ btq210).
15. Yuan Y, Savage RS, Markowetz F. 2011 Patient-specific data fusion defines prognostic cancer subtypes. PLoS Comput. Biol. 7, e1002227. (doi: 10. 1371/journal. pcbi. 1002227).
16. Kirk P, Griffin JE, Savage RS, Ghahramani Z, Wild DL. 2012 Bayesian correlated clustering to integrate multiple datasets. Bioinformatics 28, 3290-3297. (doi: 10. 1093/bioinformatics/bts595).
17. Rasmussen CE, Williams CKI 2006 Gaussian processes for machine learning. Cambridge, MA: The MIT Press.
18. Chu W, Ghahramani Z, Falciani F, Wild DL. 2005 Biomarker discovery in microarray gene expression data with Gaussian processes. Bioinformatics 21, 3385-3393. (doi: 10. 1093/bioinformatics/ bti526).
19. Kirk P, Stumpf M. 2009 Gaussian process regression bootstrapping: exploring the effects of uncertainty in time course data. Bioinformatics 25, 1300-1306. (doi: 10. 1093/bioinformatics/btp139).
20. Stegle O, Denby KJ, Cooke EJ, Wild DL, Ghahramani Z, Borgwardt KM. 2010 A robust Bayesian two-sample test for detecting intervals of differential gene expression in microarray time series. J. Comput. Biol. 17, 355-367. (doi: 10. 1089/ cmb. 2009. 0175).
21. Rasmussen C, Nickisch H. 2010 Gaussian processes for machine learning (gpml) toolbox. J. Mach. Learn. Res. 11, 3011-3015.
22. Gelman A 2004 Bayesian data analysis. Boca Raton, FL: CRC Press.
23. Girolami M, Zhong M. 2007 Data integration for classification problems employing Gaussian process priors. In Advances in Neural Information Processing Systems. Proc. of the 2006 Conf., vol. 19. Cambridge, MA: MIT Press.
24. Murray I, Adams RP. 2010 Slice sampling covariance hyperparameters of latent Gaussian models. Adv. Neural Inform. Process. Syst. 23, 1732-1740.
25. Curtis C et al. 2012 The genomic and transcriptomic architecture of 2, 000 breast tumours reveals novel subgroups. Nature 486, 346-352.
26. Breiman L. 2001 Random Forests. Mach. Learn. 45, 5-32. (doi: 10. 1023/A: 1010933404324).
27. Calabro A et al. 2009 Effects of infiltrating lymphocytes and estrogen receptor on gene expression and prognosis in breast cancer. Breast Cancer Res. Treat. 116, 69-77. (doi: 10. 1007/s10549-008-0105-3).
28. Loi S et al. 2013 Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase iii randomized adjuvant breast cancer trial in node-+ breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: big 02-98. J. Clin. Oncol. 31, 860-867. (doi: 10. 1200/JCO. 2011. 41. 0902).
29. Ratanaphan A. 2012 A DNA repair brca1 estrogen receptor and targeted therapy in breast cancer. Int. J. Mol. Sci. 13, 14 898-14 916. (doi: 10. 3390/ ijms131114898).
30. Gujam FJA, Going JJ, Edwards J, Mohammed ZMA, McMillan DC. 2014 The role of lymphatic and blood vessel invasion in predicting survival andmethods of detection in patients with primary operable breast cancer. Crit. Rev. Oncol. /Hematol. 89, 231-241. (doi: 10. 1016/j. critrevonc. 2013. 08. 014).
31. Losordo D, Isner J. 2001 Estrogen and angiogenesis a review. Arterioscler. Thromb. Vasc. Biol. 21, 6-12. (doi: 10. 1161/01. ATV. 21. 1. 6).